FDAnews
www.fdanews.com/articles/195491-mgis-dna-sequencers-cleared-in-europe-asia-pacific-countries
ClearanceStamp_Gray.gif

MGI’s DNA Sequencers Cleared in Europe, Asia-Pacific Countries

January 14, 2020

Chinese devicemaker MGI Tech has received the CE Mark and Asia-Pacific (APAC) regulatory clearance for its G and T series DNA sequencers.

The firm’s DNBSEQ-T7, G400 and G50 sequencers earned CE Mark certification. The T7 can process 60 human genomes per day and is designed for large-scale operations, while the G400/50 sequencers are benchtop devices that can adapt to a variety of applications.

The company’s G400/50 sequencers and products in the same family also received APAC clearance, and can now be marketed in China, Japan, Australia, Singapore, Malaysia, Thailand and Vietnam.

View today's stories